Prof Ramin Nilforooshan, United Kingdom
March 22, 2022
We had the opportunity to speak to Ramin Nilforooshan at ADPD 2022 to discuss the challenges that disease-modifying treatments for Alzheimer's disease may present to healthcare systems, but also the positive impact and hope that they may provide to patients.
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.